Journal
NATURE REVIEWS GENETICS
Volume 4, Issue 10, Pages 774-783Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrg1180
Keywords
-
Categories
Ask authors/readers for more resources
Since the initial characterization of the genetic defect for Duchenne muscular dystrophy, much effort has been expended in attempts to develop a therapy for this devastating childhood disease. Gene therapy was the obvious answer but, initially, the dystrophin gene and its product seemed too large and complex for this approach. However, our increasing knowledge of the organization of the gene and the role of dystrophin in muscle function has indicated ways to manipulate them both. Gene therapy for Duchenne muscular dystrophy now seems to be in reach.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available